<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-114422</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">The use of targeted therapies in Oncology and their impact in the design of clinical trials: Epidermal growth factor receptors 1 and 2 as a paradigm</dc:title>
<dc:description xml:lang="en">No disponible</dc:description>
<dc:creator>Dalmases, Alba</dc:creator>
<dc:creator>Rovira, Ana</dc:creator>
<dc:creator>Rojo, Federico</dc:creator>
<dc:creator>Albanell, Joan</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Med. clín (Ed. impr.);141(4): 176-180, ago. 2013.</dc:source>
<dc:identifier>ibc-114422</dc:identifier>
<dc:title xml:lang="es">Uso de tratamientos contra diana en Oncología y su impacto en el diseño de estudios clínicos: los receptores del factor de crecimiento epidérmico 1 y 2 como paradigma</dc:title>
<dc:subject>^d9562^s22057</dc:subject>
<dc:subject>^d974^s22078</dc:subject>
<dc:subject>^d4896^s22002</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d11665^s22053</dc:subject>
<dc:subject>^d28622^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>201308</dc:date>
</metadata>
</record>
</ibecs-document>
